Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-72.48M
↓ 62% below average
Average (9y)
$-44.63M
Historical baseline
Range
High:$27.15M
Low:$-87.17M
CAGR
+20.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-72.48M | -366.9% |
| 2023 | $27.15M | +163.2% |
| 2022 | $-42.94M | +50.7% |
| 2021 | $-87.17M | -11.3% |
| 2020 | $-78.35M | -25.4% |
| 2019 | $-62.47M | -47.3% |
| 2018 | $-42.40M | -2.5% |
| 2017 | $-41.37M | -25.6% |
| 2016 | $-32.94M | -147.4% |
| 2015 | $-13.32M | - |